UBQLN4 promotes STING proteasomal degradation during cisplatin-induced DNA damage in triple-negative breast cancer

被引：8
|
作者：
Shoji, Yoshiaki [1 ]
Yokoe, Takamichi [1 ]
Kobayashi, Yuta [1 ]
Murakami, Tomohiro [1 ]
Bostick, Peter J. [2 ]
Shiloh, Yosef [3 ]
Hoon, Dave S. B. [1 ]
Bustos, Matias A. [1 ]
机构：
[1] St Johns Canc Inst, Dept Translat Mol Med, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA
[2] Baton Rouge Gen Med Ctr, Mayo Clin Care Network, Baton Rouge, LA USA
[3] Tel Aviv Univ, Sch Med, David & Inez Myers Lab Canc Genet, Tel Aviv, Israel
来源：
CLINICAL AND TRANSLATIONAL MEDICINE | 2022年 / 12卷 / 07期
关键词：
D O I：
10.1002/ctm2.985
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] UBQLN4 regulates cisplatin-resistance in triple-negative breast cancer by targeting BAT3 for proteasomal degradation
    Shoji, Yoshiaki
    Yokoe, Takamichi
    Bostick, Peter J.
    Shiloh, Yosef
    Hoon, Dave S. B.
    Bustos, Matias A.
    CANCER RESEARCH, 2022, 82 (04)
  • [2] MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
    Dawid Mehlich
    Michał Łomiak
    Aleksandra Sobiborowicz
    Alicja Mazan
    Dagmara Dymerska
    Łukasz M. Szewczyk
    Anna Mehlich
    Agnieszka Borowiec
    Monika K. Prełowska
    Adam Gorczyński
    Paweł Jabłoński
    Ewa Iżycka-Świeszewska
    Dominika Nowis
    Anna A. Marusiak
    Cell Death & Disease, 12
  • [3] MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
    Mehlich, Dawid
    Lomiak, Michal
    Sobiborowicz, Aleksandra
    Mazan, Alicja
    Dymerska, Dagmara
    Szewczyk, Lukasz M.
    Mehlich, Anna
    Borowiec, Agnieszka
    Prelowska, Monika K.
    Gorczynski, Adam
    Jablonski, Pawel
    Izycka-Swieszewska, Ewa
    Nowis, Dominika
    Marusiak, Anna A.
    CELL DEATH & DISEASE, 2021, 12 (12)
  • [4] Modeling of Cisplatin-Induced Signaling Dynamics in Triple-Negative Breast Cancer Cells Reveals Mediators of Sensitivity
    Heijink, Anne Margriet
    Everts, Marieke
    Honeywell, Megan E.
    Richards, Ryan
    Kok, Yannick P.
    de Vries, Elisabeth G. E.
    Lee, Michael J.
    van Vugt, Marcel A. T. M.
    CELL REPORTS, 2019, 28 (09): : 2345 - +
  • [5] NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells
    Aliyaskarova, Umit
    Baiken, Yeldar
    Renaud, Flore
    Couve, Sophie
    Kisselev, Alexei F. F.
    Saparbaev, Murat
    Groisman, Regina
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells
    Umit Aliyaskarova
    Yeldar Baiken
    Flore Renaud
    Sophie Couve
    Alexei F. Kisselev
    Murat Saparbaev
    Regina Groisman
    Scientific Reports, 13
  • [7] Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
    Liang, Sixian
    Peng, Xun
    Li, Xiaoli
    Yang, Ping
    Xie, Linhao
    Li, Yaochen
    Du, Caiwen
    Zhang, Guojun
    ONCOTARGET, 2015, 6 (02) : 1020 - 1030
  • [8] A DNA damage nanoamplifier for the chemotherapy of triple-negative breast cancer via DNA damage induction and repair blocking
    Huang, Yanjuan
    Dai, Xiuling
    Guan, Zilin
    Liu, Di
    Ren, Lingling
    Chen, Meixu
    Zeng, Zishan
    Jiang, Jingwen
    Luo, Yong
    He, Yuanfeng
    Huang, Min
    Zhao, Chunshun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 622
  • [9] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells
    Zhang, Yang
    Wang, Lu
    Gao, Peng
    Sun, Zhiguo
    Li, Ning
    Lu, Yanqin
    Shen, Jianglun
    Sun, Jian
    Yang, Yiming
    Dai, Hao
    Cai, Haifeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (05) : 2343 - 2352
  • [10] An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer
    Kuthethur, Raviprasad
    Jerome, Maria Sona
    Subbannayya, Yashwanth
    Chakrabarty, Sanjiban
    BREAST CANCER, 2023, 30 (05) : 832 - 844
12345